Blood Transfusion Devices Market Report 2026

Blood Transfusion Devices Market Overview

• Blood Transfusion Devices market size has reached to $5.45 billion in 2025 • Expected to grow to $7.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.7% • Growth Driver: Rising Accidents And Trauma Cases To Drive Growth In The Blood Transfusion Devices Market • Market Trend: Innovative Blood Grouping And Testing Solutions Enhancing Accuracy And Efficiency In Blood Transfusion Devices • North America was the largest region in 2025.

What Is Covered Under Blood Transfusion Devices Market?

Blood transfusion devices are medical instruments and equipment used to facilitate the safe and efficient transfer of blood or blood components (such as red blood cells, plasma, or platelets) from a donor to a recipient. These devices are crucial in various medical settings, including surgeries, trauma care, and the treatment of certain medical conditions like anemia or clotting disorders. The main product types of blood transfusion devices are pathogen reduction systems, apheresis devices, blood component separators, blood bags and accessories, venous access devices, and others. Pathogen reduction system refers to a technology used to reduce or eliminate pathogens from blood products, ensuring safety during transfusions. The applications are cardiovascular surgeries, orthopedic surgeries, neurological surgeries, obstetrics and gynecological surgeries, and others, and it is used by various end users such as hospitals, ambulatory surgical centers, blood banks, and others.

What Is The Blood Transfusion Devices Market Growth Forecast?

The blood transfusion devices market size is expected to see strong growth in the next few years. It will grow to $7.55 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to technological advancements in automated apheresis and component separators, increasing demand for minimally invasive surgical procedures, expansion of blood bank networks, rising regulatory standards for transfusion devices, integration of smart monitoring and digital tracking in transfusion systems. Major trends in the forecast period include rising adoption of automated blood component separation systems, increasing use of pathogen reduction technologies, expansion of blood bag and accessory innovations, growth in specialized venous access devices, rising demand for blood storage and transfusion equipment.

Global Blood Transfusion Devices Market Segmentation

1) By Product Type: Pathogen Reduction System, Apheresis Devices, Blood Component Separator, Blood Bag And Accessory, Venous Access Devices, Other Product Types 2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecological Surgeries, Other Applications 3) By End User: Hospital, Ambulatory Surgical Centers, Blood Bank, Other End Users Subsegments: 1) By Pathogen Reduction System: Plasma Pathogen Reduction Devices, Platelet Pathogen Reduction Devices 2) By Apheresis Devices: Plasma Apheresis Devices, Platelet Apheresis Devices, Red Blood Cell Apheresis Devices 3) By Blood Component Separator: Automated Blood Component Separators, Manual Blood Component Separators 4) By Blood Bag and Accessory: Single Blood Bags, Double Blood Bags, Triple Blood Bags, Quadruple Blood Bags, Blood Bag Tubing and Clamps 5) By Venous Access Devices: Peripheral Venous Catheters, Central Venous Catheters, Peripherally Inserted Central Catheters (PICCs), Implantable Ports 6) By Other Product Types: Blood Warmers, Blood Mixers, Blood Transfusion Sets and Filters, Blood Storage And Refrigeration Systems

What Is The Driver Of The Blood Transfusion Devices Market?

Increasing accidents and trauma cases are expected to propel the growth of the blood transfusion devices market going forward. Accidents and trauma cases are rising due to increased urbanization, higher vehicle usage, and unsafe road conditions. Blood transfusion devices are essential in accidents and trauma cases for rapidly administering life-saving blood products to stabilize patients and manage severe hemorrhaging. For instance, in July 2024, according to the National Safety Council (NSC) Injury Facts, a US-based safety organization, motor-vehicle fatalities in the US reached 20,900 in the first half of 2024, nearly unchanged from 20,930 in the same period of 2023, despite a 0.8% increase in mileage from 2023 and a 3.1% rise from 2022. Therefore, increasing accidents and trauma cases are driving the growth of the blood transfusion devices industry.

Key Players In The Global Blood Transfusion Devices Market

Major companies operating in the blood transfusion devices market are BAG Health Care GmbH, Grifols S.A., Bio-Rad Laboratories Inc., Abbott Laboratories, Immucor Inc., Ortho Clinical Diagnostics, Siemens Healthineers, Beckman Coulter Inc., Diagast SAS, QuidelOrtho Corporation, Danaher Corporation, Becton Dickinson and Company, Quotient Biodiagnostics, Sysmex Corporation, HemoCue AB, Agena Bioscience Inc., Tulip Diagnostics P Ltd, Merck KGaA, Trinity Biotech, MTC Med Testconsult GmbH, BioMedomics Inc, Agappe Diagnostics Ltd, Day Medical SA

Global Blood Transfusion Devices Market Trends and Insights

Major companies operating in the blood transfusion devices market are focusing on developing advanced blood grouping and testing solutions to gain a competitive advantage. Blood grouping and testing solutions are medical tools and reagents used to determine a person's blood type and ensure compatibility for transfusions. For instance, in June 2024, Innobiochips, a France-based biopharmaceutical company, launched Omnys, an innovative blood transfusion device. Omnys is specifically designed for transfusion applications and enhances laboratory productivity and accuracy through multiplex analysis. This allows for high-resolution testing of blood components, including standard ABO/D typing and extended phenotyping. The device integrates various technologies to streamline the blood testing process, significantly reducing the number of wells needed for testing and minimizing waste.

What Are Latest Mergers And Acquisitions In The Blood Transfusion Devices Market?

In March 2023, Werfen S.A., a Spain-based manufacturer of biomaterials, acquired Immucor Inc. for $2 billion. This acquisition bolsters Werfen's position in the transfusion and transplant markets, enhancing its existing portfolio in hemostasis, acute care, and autoimmunity. Immucor Inc. is a US-based provider of blood transfusion devices.

Regional Outlook

North America was the largest region in the blood transfusion devices market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Blood Transfusion Devices Market?

The blood transfusion devices market consists of sales of blood warmers, needles, catheters, and filters. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.